IP 179 (Metformin ER 750 mg)

Pill imprint IP 179 has been identified as Metformin hydrochloride extended release 750 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for IP 179 (Metformin ER 750 mg)

Metformin hydrochloride extended release 750 mg IP 179
Metformin hydrochloride extended release 750 mg IP 179
Metformin hydrochloride extended release
Imprint:
IP 179
Strength:
750 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Amneal Pharmaceuticals
National Drug Code (NDC):
53746-0179
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6108 Major Pharmaceuticals
65162-0179 Amneal Pharmaceuticals
42291-0611 AvKare Inc

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)